Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 3/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3259308 | 0.89 | CA2 (0.44) | CA2NPSR1ATMGABRA1GABRB2 | |
| SCHEMBL3180640 | 0.88 | GABRA1 (0.45) | USP2ATMGABRA1GABRB2HPGD | |
| SCHEMBL3174771 | 0.84 | USP2 (0.41) | USP2ATMHPGDTDP1ALDH1A1 | |
| SCHEMBL3187499 | 0.82 | USP2 (0.37) | USP2GABRA1GABRB2HPGDALDH1A1 | |
| SCHEMBL3173883 | 0.81 | GABRA1 (0.48) | USP2GABRA1GABRB2HPGDALDH1A1 | |
| SCHEMBL3190724 | 0.81 | HPGD (0.37) | CA2USP2GABRA1GABRB2HPGD | |
| SCHEMBL3178976 | 0.80 | ALOX5 (0.39) | USP2 | |
| SCHEMBL4334985 | 0.79 | CA2 (0.42) | CA2NPSR1ATMGABRA1GABRB2 | |
| SCHEMBL3165775 | 0.78 | USP2 (0.38) | USP2NPSR1ATMHPGDTDP1 | |
| SCHEMBL3174784 | 0.76 | HPGD (0.48) | USP2NPSR1HPGDTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952189-B2 | Process for preparing diaryl carbonates or alkyl aryl carbonates from dialkyl carbonates | BAYER MATERIALSCIENCE AG (DE) | 2015-02-10 | — | — | US | disclosed |
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | HDHD5, AHR, AGL | CA2 209/4885USP2 2908/4885NPSR1 1535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.